Year |
Citation |
Score |
2018 |
Hessell AJ, Shapiro MB, Powell R, Malherbe DC, McBurney SP, Pandey S, Cheever T, Sutton WF, Kahl C, Park B, Zolla-Pazner S, Haigwood NL. Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges. Journal of Virology. PMID 29514914 DOI: 10.1128/Jvi.02198-17 |
0.32 |
|
2016 |
Trovato M, Maurano F, D'Apice L, Costa V, Sartorius R, Cuccaro F, McBurney SP, Krebs SJ, Prisco A, Ciccodicola A, Rossi M, Haigwood NL, De Berardinis P. E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. Bmc Microbiology. 16: 152. PMID 27421762 DOI: 10.1186/S12866-016-0772-X |
0.343 |
|
2016 |
McBurney SP, Sunshine JE, Gabriel S, Huynh JP, Sutton WF, Fuller DH, Haigwood NL, Messer WB. Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates. Vaccine. PMID 27085173 DOI: 10.1016/J.Vaccine.2016.03.108 |
0.641 |
|
2016 |
Hessell AJ, Malherbe DC, Pissani F, McBurney S, Krebs SJ, Gomes M, Pandey S, Sutton WF, Burwitz BJ, Gray M, Robins H, Park BS, Sacha JB, LaBranche CC, Fuller DH, et al. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens. Journal of Immunology (Baltimore, Md. : 1950). PMID 26944928 DOI: 10.4049/Jimmunol.1500527 |
0.58 |
|
2014 |
Krebs SJ, McBurney SP, Kovarik DN, Waddell CD, Jaworski JP, Sutton WF, Gomes MM, Trovato M, Waagmeester G, Barnett SJ, DeBerardinis P, Haigwood NL. Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA. Plos One. 9: e113463. PMID 25514675 DOI: 10.1371/Journal.Pone.0113463 |
0.525 |
|
2014 |
Douradinha B, McBurney SP, Soares de Melo KM, Smith AP, Krishna NK, Barratt-Boyes SM, Evans JD, Nascimento EJ, Marques ET. C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. Virus Research. 179: 231-4. PMID 24246304 DOI: 10.1016/J.Virusres.2013.11.007 |
0.418 |
|
2012 |
McBurney SP, Landucci G, Forthal DN, Ross TM. Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine. Aids Research and Human Retroviruses. 28: 1063-72. PMID 22214267 DOI: 10.1089/Aid.2011.0351 |
0.799 |
|
2011 |
Ross TM, Bhardwaj N, Eugene HS, Giles BM, McBurney SP, Rossi SL, Schneider-Ohrum K, Tang XC. Virus-Like Particle Vaccines: Advantages and Challenges Development of Vaccines: From Discovery to Clinical Testing. 97-124. DOI: 10.1002/9781118023648.ch4 |
0.363 |
|
2009 |
McBurney SP, Ross TM. Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine. 27: 4337-49. PMID 19389453 DOI: 10.1016/J.Vaccine.2009.04.032 |
0.768 |
|
2008 |
McBurney SP, Ross TM. Viral sequence diversity: challenges for AIDS vaccine designs. Expert Review of Vaccines. 7: 1405-17. PMID 18980542 DOI: 10.1586/14760584.7.9.1405 |
0.743 |
|
2007 |
McBurney SP, Ross TM. Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines. Current Pharmaceutical Design. 13: 1957-64. PMID 17627529 DOI: 10.2174/138161207781039841 |
0.719 |
|
2007 |
McBurney SP, Young KR, Ross TM. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology. 358: 334-46. PMID 17011011 DOI: 10.1016/J.Virol.2006.08.032 |
0.73 |
|
2006 |
McBurney SP, Young KR, Nwaigwe CI, Soloff AC, Cole KS, Ross TM. Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. Current Hiv Research. 4: 475-84. PMID 17073623 DOI: 10.2174/157016206778560018 |
0.734 |
|
2006 |
Young KR, McBurney SP, Karkhanis LU, Ross TM. Virus-like particles: designing an effective AIDS vaccine. Methods (San Diego, Calif.). 40: 98-117. PMID 16997718 DOI: 10.1016/J.Ymeth.2006.05.024 |
0.822 |
|
2003 |
Majumder B, Gray B, McBurney S, Schaefer TM, Dentchev T, Mahalingam S, Reinhart TA, Ayyavoo V. Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine. Immunology Letters. 89: 207-14. PMID 14556980 DOI: 10.1016/S0165-2478(03)00141-X |
0.611 |
|
Show low-probability matches. |